Researching research: Patients' experiences of participation in phase I and II anti-cancer drug trials
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The findings identify the primary psychosocial processes these patients were involved in as they progressed through the trial and in doing so highlight consequences of trial involvement that have previously remained hidden.
Abstract
Despite the ethical and practical dilemmas associated with early anti-cancer drug trials little is known about the impact of trial participation from the participant's perspective. This paper presents the key findings from part of a study that sought to fill this gap through examining the views of 55 patients who took part in a phase I or II clinical trial of a new anticancer drug treatment in a regional oncology centre, over a I-year period.The findings identify the primary psychosocial processes these patients were involved in as they progressed through the trial and in doing so highlight consequences of trial involvement that have previously remained hidden.The findings from this research therefore contribute to our understanding of the trial experience from the patients' perspective and can be used to guide and inform clinical practice in this area.
